The store will not work correctly when cookies are disabled.
2-((5,6-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-1H-benzo[d]imidazole-5-carboxamidine
ID: ALA204092
Chembl Id: CHEMBL204092
PubChem CID: 10991007
Max Phase: Preclinical
Molecular Formula: C16H12F2N6
Molecular Weight: 326.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)c1ccc2[nH]c(Cc3nc4cc(F)c(F)cc4[nH]3)nc2c1
Standard InChI: InChI=1S/C16H12F2N6/c17-8-4-12-13(5-9(8)18)24-15(23-12)6-14-21-10-2-1-7(16(19)20)3-11(10)22-14/h1-5H,6H2,(H3,19,20)(H,21,22)(H,23,24)
Standard InChI Key: HVKJPTUAFKPGTR-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 326.31 | Molecular Weight (Monoisotopic): 326.1092 | AlogP: 2.59 | #Rotatable Bonds: 3 |
Polar Surface Area: 107.23 | Molecular Species: BASE | HBA: 3 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.38 | CX Basic pKa: 10.68 | CX LogP: 1.71 | CX LogD: -0.30 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.34 | Np Likeness Score: -1.18 |
References
1. Young WB, Sprengeler P, Shrader WD, Li Y, Rai R, Verner E, Jenkins T, Fatheree P, Kolesnikov A, Janc JW, Cregar L, Elrod K, Katz B.. (2006) Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation., 16 (3): [PMID:16257204] [10.1016/j.bmcl.2005.10.023] |